Tech Company Financing Transactions

Trivascular Technologies Funding Round

Trivascular Technologies closed a $40 million Series E funding round on 11/18/2013. Investors included Deerfield Capital, Delphi Ventures and Kaiser Permanente Ventures.

Transaction Overview

Company Name
Trivascular Technologies
Announced On
11/18/2013
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series E
Investors

Deerfield Capital

Delphi Ventures (Douglas Roeder)

Kaiser Permanente Ventures (Sam Brasch)

Kearny Venture Partners (James Shapiro)

MPM Capital (James Scopa)

New Enterprise Associates (Ryan Drant)

Permal Capital

Redmile Group

Rock Springs Capital

Proceeds Purpose
Proceeds from the financing will be used to expand commercial efforts worldwide and to fuel product pipeline and clinical research activities.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
3910 Brickway Blvd.
Santa Rosa, CA 95403
USA
Phone
(949) 595-7200
Website
www.trivascular2.com
Email Address
[email protected]
Overview
Trivascular Technologies is developing novel endovascular repair devices to treat abdominal aortic aneurysms (AAA).
Profile
Trivascular Technologies LinkedIn Company Profile
Social Media
Trivascular Technologies Company Twitter Account
Company News
Trivascular Technologies News
Facebook
Trivascular Technologies on Facebook
YouTube
Trivascular Technologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Christopher Chavez
  Christopher Chavez LinkedIn Profile  Christopher Chavez Twitter Account  Christopher Chavez News  Christopher Chavez on Facebook
Chief Financial Officer
Michael Kramer
  Michael Kramer LinkedIn Profile  Michael Kramer Twitter Account  Michael Kramer News  Michael Kramer on Facebook
Chief Technical Officer
Michael Chobotov
  Michael Chobotov LinkedIn Profile  Michael Chobotov Twitter Account  Michael Chobotov News  Michael Chobotov on Facebook
VP - General Counsel
Kimberley Elting
  Kimberley Elting LinkedIn Profile  Kimberley Elting Twitter Account  Kimberley Elting News  Kimberley Elting on Facebook
VP - Manufacturing
Joseph Humphrey
  Joseph Humphrey LinkedIn Profile  Joseph Humphrey Twitter Account  Joseph Humphrey News  Joseph Humphrey on Facebook
VP - Operations
Vivek Jayaraman
  Vivek Jayaraman LinkedIn Profile  Vivek Jayaraman Twitter Account  Vivek Jayaraman News  Vivek Jayaraman on Facebook
VP - R & D
Robert Whirley
  Robert Whirley LinkedIn Profile  Robert Whirley Twitter Account  Robert Whirley News  Robert Whirley on Facebook
VP - Regulatory Affairs
Shari Quinn
  Shari Quinn LinkedIn Profile  Shari Quinn Twitter Account  Shari Quinn News  Shari Quinn on Facebook
VP - Sales
Rob Woolley
  Rob Woolley LinkedIn Profile  Rob Woolley Twitter Account  Rob Woolley News  Rob Woolley on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/18/2013: TheraVasc venture capital transaction
Next: 11/18/2013: Intelligent Business Entertainment venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.